Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
about
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-αUnderstanding the mechanism of hepatic fibrosis and potential therapeutic approachesParacrine cross-talk between skeletal muscle and macrophages in exercise by PGC-1α-controlled BNPB-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.
P2860
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@en
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@nl
type
label
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@en
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@nl
prefLabel
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@en
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@nl
P2093
P2860
P1433
P1476
Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
@en
P2093
Daisuke Taura
Kazutoshi Miyashita
Kazuwa Nakao
Kwijun Park
Masakatsu Sone
Megumi Inuzuka
Naofumi Oyamada
Naohisa Tamura
Takuhiro Sonoyama
Yasutomo Fukunaga
P2860
P304
P356
10.1016/J.FEBSLET.2009.05.025
P407
P577
2009-05-20T00:00:00Z